Clinical Trial

Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI

Study acronym: CompleteNSTEMI
Recruiting
View on ClinicalTrials.gov →
Summary
Prospective, randomized, controlled, multicenter, open-label trial to study whether multivessel percutaneous coronary intervention (PCI) is superior over culprit-lesion only PCI in patients with non-ST-segment elevation myocardial infarction (NSTEMI) and multivessel coronary artery disease.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2023-03-14; most recent amendment 2025-01-15.
Status change: Not Yet Recruiting → Recruiting 2023-10-29
Trial Details
NCT Number NCT05786131
Lead Sponsor Leipzig Heart Science gGmbH
Collaborators: Heart Center Leipzig at University of Leipzig, German Federal Ministry of Education and Research, IHF GmbH - Institut für Herzinfarktforschung, Stiftung IHF - Institut für Herzinfarktforschung
Conditions Non-ST-elevation Myocardial Infarction, Multivessel Coronary Artery Disease
Enrollment 3,390 participants
Start Date 2023-10-27
Primary Completion 2027-01-31 (estimated)
Study Completion 2027-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-01-16